<DOC>
	<DOCNO>NCT00709007</DOCNO>
	<brief_summary>Though HIV epidemic India predominantly among heterosexual population , estimate approximately 1.1 million injection drug user ( IDUs ) India HIV prevalence high 64 % among IDUs certain city . In April 2004 , government India launch free-antiretroviral therapy roll-out program aim initiate 100,000 person HAART . Similar guideline currently follow delivery choice HAART IDU non-IDU population . However , IDUs certain issue complicate delivery HAART need address delivery program delay access care , poor perceive adherence , rapid disease progression . This proposal assess feasibility effectiveness directly administer antiretroviral therapy ( DAART ) conjunction opioid substitution mode delivery HAART IDUs Chennai , India . To evaluate objective conduct randomize control pilot study DAART vs self-administered therapy ( SAT ) among 100 HIV-1 infected treatment naïve IDUs enrol opioid substitution program Chennai compare follow outcomes two arm : Primary Endpoint : Proportion participant viral load ( VL ) &lt; 400 copies/ml 24 48 week ; Secondary Endpoints : ( 1 ) Incidence mortality AIDS-defining illnesses 24 48 week , ( 2 ) Changes absolute CD4+ count baseline 24 48 week , ( 3 ) Incidence antiretroviral drug resistance 24 48 week . Intention-to-treat analysis use . The study objective line priority area identify Indian National AIDS Control Program Phase III ( NACP III ) result study help inform government India appropriate mode delivery HAART IDUs . This study also among first study conduct India evaluate two different mode delivery HAART IDUs .</brief_summary>
	<brief_title>Directly Administered Antiretroviral Therapy ( DAART ) Among HIV-1infected Injecting Drug Users ( IDUs ) Chennai , India</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<criteria>1 . 18 year age old 2 . Provide write informed consent 3 . Permanent residence less equal 15 km ( 9.5 mile ) YRGCSAR clinic 4 . Be injection drug user ( selfreport ) 5 . Satisfy criterion opioid dependence per DSMIV criterion ( see Appendix ) 6 . Urine screen must test positive presence opioids 7 . Documented evidence HIV infection ( double ELISA : Murex HIV1.2.O , Abbott Murex , UK Vironostika® HIV Uniform II Ag/Ab , Biomérieux , The Netherlands ) 8 . Be ART naïve ( selfreport ) 9 . If female childbearing potential ( follow ) Have negative urine pregnancy test Be willing use barrier base oral contraceptive duration study sexually active . 10 . Satisfy Indian National Guidelines initiation HAART ( follow ) Absolute CD4+ count &lt; 200 cells/ µl AIDSdefining illness CD4+ count Absolute CD4+ count 200 350 cell/ µl HIVrelated symptom 1 . Requires liquid preparation ART ART need dosed twice daily 2 . Indicates intention migrate next 48 week 3 . Clinical radiological sign active tuberculosis 4 . Any medical psychiatric condition study physician believe contraindication study participation . 5 . Enrolled another HIV treatment program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>